Registration No. 333-______

                       SECURITIES AND EXCHANGE COMMISSION
                                Washington, D.C.

                                    FORM S-8

                          REGISTRATION STATEMENT UNDER
                           THE SECURITIES ACT OF 1933


                               VASOMEDICAL, INC.
             (Exact name of registrant as specified in its charter)

         Delaware                                   11-2871434
(State or other jurisdiction of         (IRS Employer Identification No.)
 incorporation or organization)

180 Linden Avenue, Westbury, New York                 11590
(Address of principal executive offices)           (Zip Code)

              VASOMEDICAL, INC. 1999 STOCK OPTION PLAN, AS AMENDED
                            (Full title of the plan)

                         D. Michael Deignan, President
                               Vasomedical, Inc.
                               180 Linden Avenue
                            Westbury, New York 11590
                    (Name and address of agent for service)

                                 (516) 997-4600
         (Telephone number, including area code, of agent for service)

                                    copy to:
                            David H. Lieberman, Esq.
                    Blau, Kramer, Wactlar & Lieberman, P.C.
                             100 Jericho Quadrangle
                            Jericho, New York 11753
                                 (516) 822-4820


                        CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>

                                             Proposed maximum     Proposed maximum
Title of securities   Amount to be          offering price per   aggregate offering     Amount of
  to be registered    Registered (1)           security (2)          price (2)        registration fee
--------------------  --------------       --------------------  -------------------  -----------------

<S>                   <C>                         <C>                 <C>                <C>
Common Stock,
par value $.001
per share             2,000,000 shs.(3)(4)        $2.77               $5,540,000          $509.68

<FN>
(1)  The Registration statement also covers an indeterminate number of shares of
     Common  Stock  which may become  issuable  pursuant  to  anti-dilution  and
     adjustment provisions of the plan.

(2)  Estimated solely for the purpose of calculating the registration fee, based
     upon the average of the high and low prices of the  Company's  Common Stock
     reported on Nasdaq on April 11, 2002, pursuant to Rule 457.

(3)  Represents   additional   shares  of  Common  Stock   issuable   under  the
     Vasomedical, Inc. 1999 Stock Option Plan, as amended.

(4)  Pursuant to Rule 457, a registration fee of $509.68 is payable with respect
     to the  additional  2,000,000  shares of Common  Stock  issuable  under the
     Vasomedical, Inc. 1999 Stock Option Plan, as amended.
</FN>
</TABLE>
<PAGE>

                                    PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

     This  Registration  Statement  on Form S-8 is being  filed to  register  an
additional  2,000,000  shares of Common Stock  available for issuance  under the
Registrant's  1999 Stock  Option  Plan,  as  amended.  An  initial  Registration
Statement on Form S-8  (Registration  Statement No.  333-85457)  was  previously
filed  with  respect  to  that  plan,  as  well  as  a  Registration   Statement
(Registration Statement No. 333-42692) for the first amendment to that plan. The
contents of such earlier  Registration  Statement Nos.  333-85457 and 333- 42692
are hereby incorporated by reference.

     All documents filed pursuant to Sections 13(a),  13(c), 14 and 15(d) of the
Securities  Exchange Act of 1934 after the date of this  Registration  Statement
and prior to the termination of this offering of Common Stock shall be deemed to
be  incorporated  by reference in this  Registration  Statement and to be a part
hereof from the date of filing of such documents.  Any statement  contained in a
document  incorporated  or  deemed  to be  incorporated  by  reference  in  this
Registration Statement shall be deemed to be modified or superseded for purposes
of this Registration  Statement to the extent that a statement  contained herein
or  in  any  subsequently  filed  document  that  also  is or  is  deemed  to be
incorporated by reference  herein  modifies or supercedes  such  statement.  Any
statement so modified or superseded  shall not be deemed,  except as so modified
or superseded, to constitute a part of this Registration Statement.

     The Company  will provide  without  charge to each person to whom a copy of
this  Registration  Statement is delivered,  upon the written or oral request of
such person,  a copy of any or all of the  documents  incorporated  by reference
(except for  exhibits  thereto  unless  specifically  incorporated  by reference
therein).  Requests  for  such  copies  should  be  directed  to the  Secretary,
Vasomedical,  Inc., 180 Linden Avenue,  Westbury, New York 11590, (516) 997-4600
ext. 790.

Item 8. Exhibits.

     4    1999 Stock Option Plan, as amended

     5    Opinion and consent of Blau, Kramer, Wactlar & Lieberman, P.C.

     23.1 Consent of Blau, Kramer, Wactlar & Lieberman, P.C. - included in their
          opinion filed as Exhibit 5

     23.2 Consent of Grant Thornton LLP

     24   Power of Attorney - included in signature page hereof

<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements of the Securities Act of 1933, the Registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement to be signed on its behalf thereunto duly authorized, in Westbury, New
York on the 10th day of April,  2002.

                                        VASOMEDICAL,  INC.

                                        By:  /s/ D.  Michael Deignan
                                             D. Michael Deignan,
                                             President and Chief Executive
                                             Officer and Director
                                             (Principal Executive Officer)

                               POWER OF ATTORNEY

     KNOW ALL MEN BY THESE PRESENTS,  that each person whose  signature  appears
below  constitutes and appoints D. Michael Deignan and Joseph A. Giacalone,  and
each of them, his true and lawful  attorneys-in-fact and agents, with full power
of substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to sign any and all amendments (including post-effective
amendments)  to this  Registration  Statement  and to file  the  same,  with all
exhibits  thereto,  and  other  documents  in  connection  therewith,  with  the
Securities and Exchange  Commission,  granting unto said  attorneys-in-fact  and
agents,  and each of them,  full power and  authority to do and perform each and
every act and thing  requisite and necessary to be done, as fully to all intents
and purposes as he might or could do in person,  hereby ratifying and confirming
all that  said  attorneys-in-fact  and  agents  or any of them,  or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

     In accordance  with the  requirements  of the Securities Act of 1933,  this
registration  statement  was signed by the following  persons in the  capacities
indicated on April 10, 2002.

Signatures                          Title
----------                          -----

-------------------------       Director
Alexander G. Bearn

-------------------------       Director
David S. Blumenthal

-------------------------       Chairman of the Board
Abraham E. Cohen

/s/ D. Michael Deignan          President, Chief Executive Officer and
D. Michael Deignan              Director (Principal Executive Officer)

/s/ Joseph A. Giacalone         Secretary and Chief Financial Officer (Principal
Joseph A. Giacalone             Financial and Accounting Officer)

/s/ John C. K. Hui              Director
John C. K. Hui

-------------------------       Director
Photios T. Paulson

-------------------------       Director
Kenneth W. Rind

/s/ E. Donald Shapiro           Director
E. Donald Shapiro

/s/ Anthony Viscusi             Director
Anthony Viscusi

/s/ Forrest R. Whittaker        Director
Forrest R. Whittaker

/s/ Martin Zeiger               Director
Martin Zeiger
[{"type": "S-8", "sequence": "1", "filename": "vasos8sop1999-live.txt", "secsgml_size_bytes": 8728}]
{"company-data": {"conformed-name": "VASOMEDICAL INC", "cik": "0000839087", "assigned-sic": "3845", "irs-number": "112871434", "state-of-incorporation": "DE", "fiscal-year-end": "0531"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-86152", "film-number": "02609580"}, "business-address": {"street1": "180 LINDEN AVENUE", "city": "WESTBURY", "state": "NY", "zip": "11590", "phone": "5169974600"}, "mail-address": {"street1": "150 MOTOR PARKWAY", "street2": "SUITE 408", "city": "HAUPPAUGE", "state": "NY", "zip": "11788"}, "former-company": [{"former-conformed-name": "FUTURE MEDICAL PRODUCTS INC /DE/", "date-changed": "19920703"}, {"former-conformed-name": "FUTURE MEDICAL PRODUCTS INC /NY/", "date-changed": "19920506"}]}
Registration No. 333-______

                       SECURITIES AND EXCHANGE COMMISSION
                                Washington, D.C.

                                    FORM S-8

                          REGISTRATION STATEMENT UNDER
                           THE SECURITIES ACT OF 1933

                               VASOMEDICAL, INC.
             (Exact name of registrant as specified in its charter)

         Delaware                                   11-2871434
(State or other jurisdiction of         (IRS Employer Identification No.)
 incorporation or organization)

180 Linden Avenue, Westbury, New York                 11590
(Address of principal executive offices)           (Zip Code)

              VASOMEDICAL, INC. 1999 STOCK OPTION PLAN, AS AMENDED
                            (Full title of the plan)

                         D. Michael Deignan, President
                               Vasomedical, Inc.
                               180 Linden Avenue
                            Westbury, New York 11590
                    (Name and address of agent for service)

                                 (516) 997-4600
         (Telephone number, including area code, of agent for service)

                                    copy to:
                            David H. Lieberman, Esq.
                    Blau, Kramer, Wactlar & Lieberman, P.C.
                             100 Jericho Quadrangle
                            Jericho, New York 11753
                                 (516) 822-4820

                        CALCULATION OF REGISTRATION FEE
Proposed maximum     Proposed maximum
Title of securities   Amount to be          offering price per   aggregate offering     Amount of
  to be registered    Registered (1)           security (2)          price (2)        registration fee
--------------------  --------------       --------------------  -------------------  -----------------
Common Stock,
par value $.001
per share             2,000,000 shs.(3)(4)        $2.77               $5,540,000          $509.68
(1)  The Registration statement also covers an indeterminate number of shares of
     Common  Stock  which may become  issuable  pursuant  to  anti-dilution  and
     adjustment provisions of the plan.

(2)  Estimated solely for the purpose of calculating the registration fee, based
     upon the average of the high and low prices of the  Company's  Common Stock
     reported on Nasdaq on April 11, 2002, pursuant to Rule 457.

(3)  Represents   additional   shares  of  Common  Stock   issuable   under  the
     Vasomedical, Inc. 1999 Stock Option Plan, as amended.

(4)  Pursuant to Rule 457, a registration fee of $509.68 is payable with respect
     to the  additional  2,000,000  shares of Common  Stock  issuable  under the
     Vasomedical, Inc. 1999 Stock Option Plan, as amended.
PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

     This  Registration  Statement  on Form S-8 is being  filed to  register  an
additional  2,000,000  shares of Common Stock  available for issuance  under the
Registrant's  1999 Stock  Option  Plan,  as  amended.  An  initial  Registration
Statement on Form S-8  (Registration  Statement No.  333-85457)  was  previously
filed  with  respect  to  that  plan,  as  well  as  a  Registration   Statement
(Registration Statement No. 333-42692) for the first amendment to that plan. The
contents of such earlier  Registration  Statement Nos.  333-85457 and 333- 42692
are hereby incorporated by reference.

     All documents filed pursuant to Sections 13(a),  13(c), 14 and 15(d) of the
Securities  Exchange Act of 1934 after the date of this  Registration  Statement
and prior to the termination of this offering of Common Stock shall be deemed to
be  incorporated  by reference in this  Registration  Statement and to be a part
hereof from the date of filing of such documents.  Any statement  contained in a
document  incorporated  or  deemed  to be  incorporated  by  reference  in  this
Registration Statement shall be deemed to be modified or superseded for purposes
of this Registration  Statement to the extent that a statement  contained herein
or  in  any  subsequently  filed  document  that  also  is or  is  deemed  to be
incorporated by reference  herein  modifies or supercedes  such  statement.  Any
statement so modified or superseded  shall not be deemed,  except as so modified
or superseded, to constitute a part of this Registration Statement.

     The Company  will provide  without  charge to each person to whom a copy of
this  Registration  Statement is delivered,  upon the written or oral request of
such person,  a copy of any or all of the  documents  incorporated  by reference
(except for  exhibits  thereto  unless  specifically  incorporated  by reference
therein).  Requests  for  such  copies  should  be  directed  to the  Secretary,
Vasomedical,  Inc., 180 Linden Avenue,  Westbury, New York 11590, (516) 997-4600
ext. 790.

Item 8. Exhibits.

     4    1999 Stock Option Plan, as amended

     5    Opinion and consent of Blau, Kramer, Wactlar & Lieberman, P.C.

     23.1 Consent of Blau, Kramer, Wactlar & Lieberman, P.C. - included in their
          opinion filed as Exhibit 5

     23.2 Consent of Grant Thornton LLP

     24   Power of Attorney - included in signature page hereof
SIGNATURES

     Pursuant to the  requirements of the Securities Act of 1933, the Registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement to be signed on its behalf thereunto duly authorized, in Westbury, New
York on the 10th day of April,  2002.

                                        VASOMEDICAL,  INC.

                                        By:  /s/ D.  Michael Deignan
                                             D. Michael Deignan,
                                             President and Chief Executive
                                             Officer and Director
                                             (Principal Executive Officer)

                               POWER OF ATTORNEY

     KNOW ALL MEN BY THESE PRESENTS,  that each person whose  signature  appears
below  constitutes and appoints D. Michael Deignan and Joseph A. Giacalone,  and
each of them, his true and lawful  attorneys-in-fact and agents, with full power
of substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to sign any and all amendments (including post-effective
amendments)  to this  Registration  Statement  and to file  the  same,  with all
exhibits  thereto,  and  other  documents  in  connection  therewith,  with  the
Securities and Exchange  Commission,  granting unto said  attorneys-in-fact  and
agents,  and each of them,  full power and  authority to do and perform each and
every act and thing  requisite and necessary to be done, as fully to all intents
and purposes as he might or could do in person,  hereby ratifying and confirming
all that  said  attorneys-in-fact  and  agents  or any of them,  or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

     In accordance  with the  requirements  of the Securities Act of 1933,  this
registration  statement  was signed by the following  persons in the  capacities
indicated on April 10, 2002.

Signatures                          Title
----------                          -----

-------------------------       Director
Alexander G. Bearn

-------------------------       Director
David S. Blumenthal

-------------------------       Chairman of the Board
Abraham E. Cohen

/s/ D. Michael Deignan          President, Chief Executive Officer and
D. Michael Deignan              Director (Principal Executive Officer)

/s/ Joseph A. Giacalone         Secretary and Chief Financial Officer (Principal
Joseph A. Giacalone             Financial and Accounting Officer)

/s/ John C. K. Hui              Director
John C. K. Hui

-------------------------       Director
Photios T. Paulson

-------------------------       Director
Kenneth W. Rind

/s/ E. Donald Shapiro           Director
E. Donald Shapiro

/s/ Anthony Viscusi             Director
Anthony Viscusi

/s/ Forrest R. Whittaker        Director
Forrest R. Whittaker

/s/ Martin Zeiger               Director
Martin Zeiger